University of Florida Health researchers have been awarded a $2.3 million grant to screen 1,000+ patients at health center outpatient practices to determine the pervasiveness of liver scarring.
We are very excited to welcome our newest first year fellows to the UF Division of Endocrinology, Diabetes, and Metabolism from 2020-2022!
In honor of National Diabetes Awareness Month, the University of Florida Diabetes Institute (UFDI) will host a series of events designed to engage our campus community, the Gainesville population, and key diabetes stakeholders for our state of Florida. The University of Florida’s Diabetes Institute showcased the research…
The annual Endocrine Society Conference showcased our faculty & fellows' cutting-edge research in patient care & treatment.
"The story of nonalcoholic fatty liver disease, or NAFLD, is often filled with missed opportunities to catch the disease before it grows into life-threatening cirrhosis, especially for patients with Type 2 diabetes"
Endocrinology Fellowship Program Congratulations to Danielle Eagan, Morolake Amole and Alexis da Silva for matching in the 2018-2020 Endocrinology Fellowship program at the University of Florida. It is an honor to have these talented individuals join our team. …
GAINESVILLE, Fla. — A University of Florida researcher with a $2 million federal grant is launching the first Phase III clinical trial for treatment of a congenital disease of the mitochondria, the energy powerhouse of cells. A Phase III trial assesses a treatment’s efficacy in patients and is one…
Welcome Dr. Whitney W. Woodmansee The Division of Endocrinology, Diabetes & Metabolism is proud and excited to welcome Dr. Whitney Woodmansee to our Endocrine family! She comes to us from Mayo Clinic in Jacksonville, Florida. She has held appointments at Harvard Medical School and Health Sciences Center at the University…
A three-year clinical trial led by University of Florida Health researcher Kenneth Cusi, M.D., found that the drug pioglitazone is safe and effective in certain patients who have nonalcoholic steatohepatitis, or NASH, a chronic liver disease caused by a buildup of fat. The findings are published today (June 20) in…
Dear friends, It has been a month since the unexpected passing of our friend and colleague Chris Newton on May 29th, 2016. In honor of his many contributions to patients and peers, we have set-up the “Chris Newton MD Excellence in Education and Diabetes Care Award” at the…
